IL6 and colonic neoplasm: Additionally, PXR showcases the ability to modulate the proliferation and apoptosis dynamics of colon cancer cells and thwart chronic colitis‐associated cancer (CAC) cell proliferation by engaging with cytokines such as IL‐6.8